Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lavasept 0.04% Efficacy and Tolerability in Acute Traumatic Wounds
NCT01153620Phase 4Completed
- Sponsor
- B. Braun
- Start
- Aug 2010
- Primary completion
- Jan 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of polihexanide in traumatic wound, sponsored by B. Braun. Started Aug 2010; status: completed.
02
Drugs
polihexanide
03
Conditions
traumatic wound
Beyond the preview
Go deeper on NCT01153620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01153620.